- Home
- CGC vs TALKW Comparison
CGC vs TALKW Comparison
Compare CGC & TALKW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CGC | TALKW |
|---|---|---|
| Founded | N/A | 2012 |
| Country | Canada | United States |
| Employees | N/A | 521 |
| Industry | Pharmaceuticals and Biotechnology | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.3M | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CGC | TALKW |
|---|---|---|
| Price | $1.31 | $0.03 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 52.9M | 64.2K |
| Earning Date | 02-06-2026 | 02-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $200,022,256.00 | $181,291,000.00 |
| Revenue This Year | $6.79 | N/A |
| Revenue Next Year | $7.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 31.50 |
| 52 Week Low | $0.77 | $0.20 |
| 52 Week High | $3.07 | $0.24 |
Technical Indicators
Market Signals| Indicator | CGC | TALKW |
|---|---|---|
| Relative Strength Index (RSI) | 48.29 | 37.10 |
| Support Level | $1.54 | $0.03 |
| Resistance Level | $2.38 | $0.07 |
| Average True Range (ATR) | 0.25 | 0.01 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 17.05 | 17.76 |
Price Performance
Historical ComparisonAbout CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.
About TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.